Delivery Order SPE2DB22D1103-SPE2DB25FTTN2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,043.64 to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits on August 26, 2025, with completion scheduled for August 27, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lupron Depot is a hormone therapy medication used in the treatment of conditions including prostate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Lupron Depot 11.25 mg 3-month treatment kits valued at $22,525.47. This competitive award employs firm fixed pricing and is scheduled for completion by September 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,483.53 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting military and federal healthcare systems through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits valued at $29,864.38. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is due for completion by July 30, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,949.64 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,331.98 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits under a firm fixed price contract. The award was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a non-set-aside award issued competitively to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company is headquartered. Lupron Depot is a hormone therapy...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,201.87 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order under a non-set-aside competitive procurement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Lupron Depot 11.25 mg 3-month kits, valued at $4,474.82 with a firm fixed price structure. This competitively awarded delivery order, with no set-aside designation, is scheduled for completion by August 18, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $20,048.58 to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026,...
- The Defense Logistics Agency awarded a delivery order valued at $9,014.39 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 3.75 mg kits. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lupron Depot is a leuprolide acetate-based pharmaceutical product used in hormonal therapies, and this order represents a single delivery transaction under the...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTTN2Delivery Order
The Defense Logistics Agency awarded a $28,548.57 delivery order to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month treatment kits on August 4, 2025, with a completion date of August 5, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lupron Depot is a hormone therapy medication commonly used in military and federal healthcare systems for treating conditions such as prostate cancer and endometriosis. This delivery order falls under AmerisourceBergen Drug Corp's larger $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and running through December 2026. This prime contract vehicle enables the pharmaceutical distributor to supply a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant federal contracting portfolio with DLA, fulfilling critical medical procurement needs across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.5k | 8/4/25 |